048530 — iNtRON Biotechnology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Market Cap
KR₩130bn
Enterprise Value
KR₩82bn
Revenue
KR₩6bn

Annual balance sheet for iNtRON Biotechnology, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	66,169	83,497	47,351	57,184	49,843
Net Total Accounts Receivable
Net Total Receivables	12,207	40,641	65,268	2,697	1,203
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	81,327	125,513	113,928	60,980	52,226
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11,951	13,758	15,031	22,696	19,740
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	100,536	153,365	140,959	98,615	86,375
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12,704	33,254	32,218	786	1,338
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	15,157	52,016	34,777	1,880	2,602
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	85,379	101,349	106,181	96,734	83,773
Total Liabilities & Shareholders' Equity	100,536	153,365	140,959	98,615	86,375
Total Common Shares Outstanding
Total Preferred Shares Outstanding